Drug Type Monoclonal antibody |
Synonyms MM 151 |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
RAS/BRAF Wild Type Colorectal Cancer | Phase 2 | - | 01 Jul 2016 | |
Colorectal Cancer | Phase 2 | - | - | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Jan 2012 | |
Non-Small Cell Lung Cancer | Phase 1 | US | 01 Jan 2012 | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | US | 01 Jan 2012 | |
Triple Negative Breast Cancer | Phase 1 | US | 01 Jan 2012 |
Phase 1 | 112 | cluxpqifhi(scjcpaywsa) = etrwktogvu iwgyzqehjs (neqxuxijnl ) | - | 20 Jan 2015 | |||
cluxpqifhi(scjcpaywsa) = cmtoyxuptp iwgyzqehjs (neqxuxijnl ) |